Nam-Kyong Choi

Dr. Nam-Kyong Choi


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Ophthalmology
Verified
Journal Article
Closed access
SPSang Park
Sang Park
NCNam-Kyong Choi
Nam-Kyong Choi
BYBo Ram Yang
Bo Ram Yang
KPKyu Hyung Park
Kyu Hyung Park
JLJoongyub Lee
Joongyub Lee
Se Joon WooSe Joon Woo
Se Joon Woo

1 October 2014 in Ophthalmology
Verified
Journal Article
Closed access
SPSang Park
Sang Park
NCNam-Kyong Choi
Nam-Kyong Choi
KSKyung Ha Seo
Kyung Ha Seo
KPKyu Hyung Park
Kyu Hyung Park
Se Joon WooSe Joon Woo
Se Joon Woo

1 May 2015 in The American Journal of Medicine
Verified
Journal Article
Closed access
SKSeoyoung C. Kim
Seoyoung C. Kim
MKMi-Sook Kim
Mi-Sook Kim
GSGABRIEL SANFELIX
GABRIEL SANFELIX
HSHong Ji Song
Hong Ji Song
JLJun Liu
Jun Liu
JAJerry Avorn
Jerry Avorn

31 July 2012 in Journal of Preventive Medicine and Public Health
Verified
Journal Article
Open access
PDF file
DKDong Yoon Kang
Dong Yoon Kang
SPSoyoung Park
Soyoung Park
CRChul-Woo Rhee
Chul-Woo Rhee
YKYe-Jee Kim
Ye-Jee Kim
NCNam-Kyong Choi
Nam-Kyong Choi
BPByung-Joo Park
Byung-Joo Park
Kang DY, et al. J Prev Med Public Health. 2012 Jul;45(4):219-226. http://dx.doi.org/10.3961/jpmph.2012.45.4.219

16 October 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BKBo Kyung Koo
Bo Kyung Koo
CLChang-Hoon Lee
Chang-Hoon Lee
BYBo Ram Yang
Bo Ram Yang
SHSeung-Sik Hwang
Seung-Sik Hwang
NCNam-Kyong Choi
Nam-Kyong Choi
The incidence and prevalence of type 2 diabetes mellitus (T2DM) and related macrovascular complications in Korea were estimated using the Health Insurance Review and Assessment (HIRA) database from 2007–2011, which covers the claim data of 97.0% of the Korean population. T2DM, coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral artery disease (PAD) were defined according to ICD-10 codes. We used the Healthcare Common Procedure Coding System codes provided by HIRA to identify associated procedures or surgeries. When calculating incidence, we excluded cases with preexisting T2DM within two years before the index year. A Poisson distribution was assumed when calculating 95% confidence intervals for prevalence and incidence rates. The prevalence of T2DM in Korean adults aged 20–89 years was 6.1–6.9% and the annual incidence rates of T2DM ranged from 9.5–9.8/1,000 person-year (PY) during the study period. The incidence rates of T2DM in men and women aged 20–49 years showed decreasing patterns from 2009 to 2011 (P<0.001); by contrast, the incidence in subjects aged 70–79 years showed increased patterns from 2009 to 2011 (P<0.001). The incidence rates of CAD and CVD in patients newly diagnosed with T2DM were 18.84/1,000 PY and 11.32/1,000 PY, respectively, in the year of diagnosis. Among newly diagnosed individuals with T2DM who were undergoing treatment for PAD, 14.6% underwent angioplasty for CAD during the same period. Our study measured the national incidences of T2DM, CAD, CVD, and PAD, which are of great concern for public health. We also confirmed the relatively higher risk of CAD and CVD newly detected T2DM patients compared to the general population in Korea.

1 October 2015 in Ophthalmology
Verified
Journal Article
Closed access
SPSang Jun Park
Sang Jun Park
KKKyoung-Eun Kwon
Kyoung-Eun Kwon
NCNam-Kyong Choi
Nam-Kyong Choi
KPKyu Hyung Park
Kyu Hyung Park
Se Joon WooSe Joon Woo
Se Joon Woo